Discontinued — last reported Q4 '23
Cigna Other Pharmacy — Revenue increased by 6.3% to $2.54B in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 45.7%, from $1.74B to $2.54B. Over 2 years (FY 2021 to FY 2023), Other Pharmacy — Revenue shows an upward trend with a 18.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests successful monetization of ancillary services or growth in non-core business lines, while a decrease may indicate a strategic shift away from these activities or a decline in secondary service demand.
This metric represents the aggregate revenue generated from business activities that do not fall under the company's pri...
Peers in the managed care and PBM space often report similar 'Other' or 'Corporate' revenue lines, though the composition varies significantly based on how each company classifies its non-core service offerings.
ci_segment_other_revenues_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.62B | $1.70B | $1.72B | $1.71B | $1.67B | $1.63B | $1.74B | $1.87B | $2.25B | $2.39B | $2.54B |
| QoQ Change | — | +5.1% | +1.1% | -0.5% | -2.6% | -2.2% | +7.0% | +7.1% | +20.5% | +6.3% | +6.3% |
| YoY Change | — | — | — | — | +3.0% | -4.2% | +1.4% | +9.1% | +34.9% | +46.6% | +45.7% |